PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,556,000 | -73.1% | 144,624 | -68.2% | 0.20% | -50.2% |
Q2 2019 | $5,774,000 | -73.9% | 454,300 | -20.4% | 0.40% | -61.0% |
Q1 2019 | $22,141,000 | +129.5% | 570,800 | +20.4% | 1.02% | +54.1% |
Q4 2018 | $9,647,000 | +147.3% | 474,100 | +457.1% | 0.66% | +198.2% |
Q3 2018 | $3,901,000 | -22.5% | 85,100 | 0.0% | 0.22% | -24.4% |
Q2 2018 | $5,033,000 | +158.5% | 85,100 | +332.0% | 0.30% | +183.7% |
Q4 2017 | $1,947,000 | -46.6% | 19,700 | -83.4% | 0.10% | -65.3% |
Q4 2016 | $3,644,000 | – | 118,700 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |